OptimizeRx Corporation (OPRX)
Stock Price:
$20.05 USD
-1.06 (-5.02%)
Updated Oct 28, 2020 1:38 PM EDT - Market open
Key Info
| Market Cap |
301.61M |
| Revenue (ttm) |
28.75M |
| Net Income (ttm) |
-6.84M |
| Shares Out |
15.04M |
| EPS (ttm) |
-0.47 |
| PE Ratio |
n/a |
| Forward PE |
67.57 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 28, 2020 |
| Last Price |
$20.05 |
| Previous Close |
$21.11 |
| Change ($) |
-1.06 |
| Change (%) |
-5.02% |
| Day's Open |
20.78 |
| Day's Range |
19.93 - 20.84 |
| Day's Volume |
61,390 |
| 52-Week Range |
6.50 - 22.55 |
More Stats
| Market Cap |
301.61M |
| Enterprise Value |
287.62M |
| Earnings Date (est) |
Nov 9, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
15.04M |
| Float |
12.30M |
| EPS (basic) |
-0.47 |
| EPS (diluted) |
-0.47 |
| FCF / Share |
-0.42 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1.20M |
| Short Ratio |
5.24 |
| Short % of Float |
9.76% |
| Beta |
0.55 |
| PE Ratio |
n/a |
| Forward PE |
67.57 |
| P/FCF Ratio |
n/a |
| PS Ratio |
10.49 |
| PB Ratio |
7.46 |
| Revenue |
28.75M |
| Operating Income |
-7.62M |
| Net Income |
-6.84M |
| Free Cash Flow |
-6.15M |
| Net Cash |
13.99M |
| Net Cash / Share |
0.93 |
| Gross Margin |
53.70% |
| Operating Margin |
-26.51% |
| Profit Margin |
-23.80% |
| FCF Margin |
-21.37% |
| ROA |
-7.43% |
| ROE |
-16.01% |
| ROIC |
-251.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$30.33*
(51.27% upside)
Low
21.0
Current: $20.05
High
40.0
Target: 30.33
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 24.60 | 21.21 | 12.13 | 7.75 | 7.22 | 6.50 | 4.68 | 1.99 | 1.11 | 0.07 |
| Revenue Growth | 15.99% | 74.86% | 56.45% | 7.35% | 11.04% | 38.96% | 135.27% | 78.95% | 1464.09% | - |
| Gross Profit | 15.44 | 12.21 | 5.95 | 4.34 | 3.60 | 3.28 | 2.82 | 1.87 | 1.11 | 0.07 |
| Operating Income | -3.69 | 0.18 | -2.13 | -1.58 | -0.60 | -1.03 | -0.27 | -0.45 | -1.45 | -1.85 |
| Net Income | -3.14 | 0.23 | -2.10 | -1.54 | -0.60 | -1.03 | -0.27 | -0.45 | -2.12 | -2.01 |
| Shares Outstanding | 13.39 | 10.83 | 9.82 | 9.90 | 2.73 | 2.49 | 1.60 | 1.58 | 1.55 | 1.47 |
| Earnings Per Share | -0.23 | 0.02 | -0.21 | -0.16 | -0.18 | -0.36 | -0.18 | -0.27 | -1.35 | -1.35 |
| Operating Cash Flow | -1.66 | 0.79 | -1.48 | -0.47 | 0.52 | -0.06 | 1.13 | -0.62 | -0.52 | -1.31 |
| Capital Expenditures | -0.09 | -0.03 | -0.04 | -0.18 | - | -0.01 | - | - | -0.01 | - |
| Free Cash Flow | -1.75 | 0.76 | -1.52 | -0.64 | 0.51 | -0.06 | 1.13 | -0.63 | -0.53 | -1.31 |
| Cash & Equivalents | 18.85 | 8.91 | 5.12 | 7.03 | 8.21 | 3.45 | 1.12 | 0.28 | 0.96 | 1.28 |
| Total Debt | - | - | - | - | - | - | - | - | - | 1.00 |
| Net Cash / Debt | 18.85 | 8.91 | 5.12 | 7.03 | 8.21 | 3.45 | 1.12 | 0.28 | 0.96 | 0.28 |
| Assets | 56.64 | 25.05 | 9.76 | 11.48 | 12.31 | 7.03 | 3.95 | 2.18 | 2.89 | 3.75 |
| Liabilities | 11.78 | 6.60 | 3.54 | 3.67 | 3.37 | 2.42 | 2.28 | 0.77 | 1.30 | 1.85 |
| Book Value | 44.86 | 18.46 | 6.22 | 7.81 | 8.94 | 4.61 | 1.67 | 1.40 | 1.59 | 1.89 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
OptimizeRx Corporation |
| Country |
United States |
| Employees |
70 |
| CEO |
William J. Febbo |
Stock Information
| Ticker Symbol |
OPRX |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Health Information Services |
| Unique Identifier |
NASDAQ: OPRX |
Description
OptimizeRx Corporation operates as a digital health company that facilitates communication at point-of-care among various stakeholders in healthcare. Its cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, and critical clinical information; and network consists of electronic health record company platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and clinical messaging services. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.